Liposomes containing recombinant gp85 protein vaccine against ALV-J in chickens

Vaccine

Volumn 32, Issue 21, 2014, Pages 2452-2456

  Zhang, Limei ^a   Cai, Dongjie ^a   Zhao, Xiaona ^a   Cheng, Ziqiang ^a   Guo, Huijun ^a   Qi, Chunhua ^b   Liu, Jianzhu ^a   Xu, Ruixue ^a   Zhao, Peng ^a   Cui, Zhizhong ^a  

^a SHANDONG AGRICULTURAL UNIVERSITY   (China)

^b Tai'an Central Hospital   (China)

Author keywords

ALV J; Chicken; Liposomes; Recombinant gp85 protein; Viremia

Indexed keywords

ANTIBODY; FREUND ADJUVANT; LIPOSOME; RECOMBINANT GP85 PROTEIN VACCINE; UNCLASSIFIED DRUG; VACCINE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIBODY BLOOD LEVEL; ANTIBODY RESPONSE; ARTICLE; AVIAN LEUKOSIS ONCOVIRUS; AVIAN LEUKOSIS VIRUS J; BLOOD SAMPLING; CHICKEN; CONTROLLED STUDY; DRUG SAFETY; IMMUNOASSAY; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECOMBINANT PLASMID; VACCINATION; VIREMIA; VIRUS PURIFICATION; WESTERN BLOTTING;

ALV-J; CHICKEN; LIPOSOMES; RECOMBINANT GP85 PROTEIN; VIREMIA;

ANIMALS; ANTIBODIES, VIRAL; ANTIGENS, VIRAL; AVIAN LEUKOSIS; AVIAN LEUKOSIS VIRUS; CHICKENS; FREUND'S ADJUVANT; LIPOSOMES; POULTRY DISEASES; VACCINES, SYNTHETIC; VIRAL ENVELOPE PROTEINS; VIRAL VACCINES;

EID: 84898443221     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2014.02.091     Document Type: Article

References (33)

1. Payne L., Brown S., Bumstead N., Howes K., Frazier J.A., Thouless M.E. A novel subgroup of exogenous avian leukosis virus in chickens. J Gen Virol 1991, 72:801-807.
2. Stedman N., Brown T. Body weight suppression in broilers naturally infected with avian leukosis virus subgroup J. Avian Dis 1999, 604-610.
3. Gao Y., Yun B., Qin L., Pan W., Qu Y., Liu Z., et al. Molecular epidemiology of avian leukosis virus subgroup J in layer flocks in China. J Clin Microbiol 2012, 50(3):953-960.
4. Pan W., Gao Y., Qin L., Ni W., Liu Z., Yun B., et al. Genetic diversity and phylogenetic analysis of glycoprotein GP85 of ALV-J isolates from Mainland China between 1999 and 2010: coexistence of two extremely different subgroups in layers. Vet Microbiol 2012, 156(1):205-212.
5. Cui Z., Sun S., Zhang Z., Meng S. Simultaneous endemic infections with subgroup J avian leukosis virus and reticuloendotheliosis virus in commercial and local breeds of chickens. Avian Pathol 2009, 38(6):443-448.
6. Allison A., Gregoriadis G. Liposomes as immunological adjuvants. Nature 1974, 252(5480):252.
7. Watson D.S., Endsley A.N., Huang L. Design considerations for liposomal vaccines: influence of formulation parameters on antibody and cell-mediated immune responses to liposome associated antigens. Vaccine 2012, 30(13):2256-2272.
8. Faisal S.M., Yan W., McDonough S.P., Chang Y.-F. Leptospira immunoglobulin-like protein A variable region (LigAvar) incorporated in liposomes and PLGA microspheres produces a robust immune response correlating to protective immunity. Vaccine 2009, 27(3):378-387.
9. Rosenkrands I., Vingsbo-Lundberg C., Bundgaard T.J., Lindenstrøm T., Enouf V., van der Werf S., et al. Enhanced humoral and cell-mediated immune responses after immunization with trivalent influenza vaccine adjuvanted with cationic liposomes. Vaccine 2011, 29(37):6283-6291.
10. Mallick A., Singha H., Chaudhuri P., Nadeem A., Khan S.A., Dar K.A., et al. Liposomised recombinant ribosomal L7/L12 protein protects BALB c mice against Brucella abortus 544 infection. Vaccine 2007, 25(18):3692-3704.
11. Sanchez Y., Ionescu-Matiu I., Dreesman G.R., Kramp W., Six H.R., Hollinger F.B., et al. Humoral and cellular immunity to hepatitis B virus-derived antigens: comparative activity of Freund complete adjuvant alum, and liposomes. Infect Immun 1980, 30(3):728-733.
12. Torchilin V.P. Recent advances with liposomes as pharmaceutical carriers. Nat Rev Drug Discov 2005, 4(2):145-160.
13. Tollemar J., Klingspor L., Ringden O. Liposomal amphotericin B (AmBisome) for fungal infections in immunocompromised adults and children. Clin Microbiol Infect 2001, 7(s2):68-79.
14. Stewart S., Jablonowski H., Goebel F.D., Arasteh K., Spittle M., Rios A., et al. Randomized comparative trial of pegylated liposomal doxorubicin versus bleomycin and vincristine in the treatment of AIDS-related Kaposi's sarcoma. International Pegylated Liposomal Doxorubicin Study Group. J Clin Oncol 1998, 16(2):683-691.
15. Gregoriadis G. Immunological adjuvants: a role for liposomes. Immunol Today 1990, 11:89-97.
16. Zhang J., Cui Z., Ding J., Jiang S. Construction of infectious clone of subgroup J avian leukosis virus strain NX0101 and its pathogenicity. Acta Microbiol Sin 2005, 45(3):437.
17. Singh M., O'Hagan D.T. Recent advances in veterinary vaccine adjuvants. Int J Parasitol 2003, 33(5-6):469-478.
18. Kulkarni S., Dipali S., Betageri G. Protamine induced aggregation of unilamellar liposomes. Pharm Pharmacol Commun 1995, 1(8):359-362.
19. Swayne D.E., Glisson J.R., Jackwood M.W., Pearson J.E., Reed W.M. A laboratory manual for the isolation and identification of avian pathogens 1998, American Association of Avian Pathologists, Philadelphia, PA.
20. Payne L.N., Nair V. The long view: 40 years of avian leukosis research. Avian Pathol 2012, 41(1):11-19.
21. Venugopal K., Smith L., Howes K., Payne L. Antigenic variants of J subgroup avian leukosis virus: sequence analysis reveals multiple changes in the env gene. J Gen Virol 1998, 79(4):757-766.
22. Wu X., Qian K., Qin A., Shen H., Wang P., Jin W., et al. Recombinant avian leukosis viruses of subgroup J isolated from field infected commercial layer chickens with hemangioma and myeloid leukosis possess an insertion in the E element. Vet Res Commun 2010, 34(7):619-632.
23. Zavala G., Cheng S., Jackwood M.W. Molecular epidemiology of avian leukosis virus subgroup J and evolutionary history of its 3' untranslated region. Avian Dis 2007, 51(4):942-953.
24. Venugopal K. Avian leukosis virus subgroup J: a rapidly evolving group of oncogenic retroviruses. Res Vet Sci 1999, 67(2):113-119.
25. Cui Z., Du Y., Zhang Z., Silva R.F. Comparison of Chinese field strains of avian leukosis subgroup J viruses with prototype strain HPRS-103 and United States strains. Avian Dis 2003, 47(4):1321-1330.
26. Xu B., Dong W., Yu C., He Z., Lv Y., Sun Y., et al. Occurrence of avian leukosis virus subgroup J in commercial layer flocks in China. Avian Pathol 2004, 33(1):13-17.
27. Cheng Z., Zhang L., Liu S., Zhang L., Cui Z. Emerging of avian leukosis virus subgroup J in a flock of Chinese local breed. Acta Microbiol Sin 2005, 45(4):584.
28. Sun S., Cui Z. Epidemiological and pathological studies of subgroup J avian leukosis virus infections in Chinese local "yellow" chickens. Avian Pathol 2007, 36(3):221-226.
29. Dou W., Li H., Cheng Z., Zhao P., Liu J., Cui Z., et al. Maternal antibody induced by recombinant gp85 protein vaccine adjuvanted with CpG-ODN protects against ALV-J early infection in chickens. Vaccine 2013, 31(51):6144-6149.
30. Zhang S.H., Liang J.X., Dai S.Y., Qiu X.L., Yi Y.R., Pan Y. Immunological effect of subunit influenza vaccine entrapped by liposomes. Biomed Environ Sci 2009, 22(5):388-393.
31. Babai I., Samira S., Barenholz Y., Zakay-Rones Z., Kedar E. A novel influenza subunit vaccine composed of liposome-encapsulated haemagglutinin/neuraminidase and IL-2 or GM-CSF. I. Vaccine characterization and efficacy studies in mice. Vaccine 1999, 17(9-10):1223-1238.
32. Barnier Quer C., Elsharkawy A., Romeijn S., Kros A., Jiskoot W. Cationic liposomes as adjuvants for influenza hemagglutinin: more than charge alone. Eur J Pharm Biopharm 2012, 81(2):294-302.
33. Aguilar J.C., Rodríguez E.G. Vaccine adjuvants revisited. Vaccine 2007, 25(19):3752-3762.